Pharmacokinetics of L-arginine in adults with moderately severe malaria

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 12, 2008, Pages 4381-4387

  Yeo, Tsin W ^a   Rooslamiati, Indri ^b   Gitawati, Retno ^b   Tjitra, Emiliana ^b   Lampah, Daniel A ^b,c   Kenangalem, Enny ^b,c   McNeil, Yvette R ^a   Price, Richard N ^a,d,e   Anstey, Nicholas M ^a,e   Duffull, Stephen B ^f  

^a MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^b NATIONAL INSTITUTE OF HEALTH RESEARCH AND DEVELOPMENT   (Indonesia)

^c District Ministry of Health   (Indonesia)

^d CHURCHILL HOSPITAL   (United Kingdom)

^e Royal Darwin Hospital   (New Zealand)

^f UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE;

ADULT; ARTICLE; CONTROL GROUP; CONTROLLED STUDY; COVARIANCE; DISEASE SEVERITY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG HALF LIFE; ETHNICITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MALE; POPULATION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANIMALS; ARGININE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; NITRIC OXIDE; PLASMODIUM FALCIPARUM; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 57049147609     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00421-08     Document Type: Article

References (35)

1. Anstey, N. M., J. B. Weinberg, M. Y. Hassanali, E. D. Mwaikambo, D. Manyenga, M. A. Misukonis, D. R. Arnelle, D. Hollis, M. I. McDonald, and D. L. Granger. 1996. Nitric oxide in Tanzanian children with malaria: inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression. J. Exp. Med. 184:557-567.
2. Argaman, Z., V. R. Young, N. Noviski, L. Castillo-Rosas, X. M. Lu, D. Zurakowski, M. Cooper, C. Davison, J. F. Tharakan, A. Ajami, and L. Castillo. 2003. Arginine and nitric oxide metabolism in critically ill septic pediatric patients. Crit. Care Med. 31:591-597.
3. Beal, S. L., and L. Sheiner. 1998. NONMEM user's guide, parts I to VII. NONMEM Project Group, San Francisco, CA.
4. Bode-Böger, S. M., R. H. Böger, A. Galland, D. Tsikas, and J. C. Frolich. 1998. L-arginine-induced vasodilation in healthy humans: pharmacokinetic-pharmacodynamic relationship. Br. J. Clin. Pharmacol. 46:489-497.
5. Böger, R. H., and S. M. Bode-Böger. 2001. The clinical pharmacology of L-arginine. Annu. Rev. Pharmacol. Toxicol. 41:79-99.
6. Closs, E. I., A. Simon, N. Vekony, and A. Rotmann. 2004. Plasma membrane transporters for arginine. J. Nutr. 134:2752S-2759S; discussion, 2765S-2767S.
7. De Caterina, R., P. Libby, H. B. Peng, V. J. Thannickal, T. B. Rajavashisth, M. A. Gimbrone, Jr., W. S. Shin, and J. K. Liao. 1995. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J. Clin. Investig. 96:60-68.
8. Dondorp, A., F. Nosten, K. Stepniewska, N. Day, and N. White. 2005. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet 366:717-725.
9. Dondorp, A. M., E. Pongponratn, and N. J. White. 2004. Reduced microcirculatory flow in severe falciparum malaria: pathophysiology and electron-microscopic pathology. Acta Trop. 89:309-317.
10. Golenser, J., J. McQuillan, L. Hee, A. J. Mitchell, and N. H. Hunt. 2006. Conventional and experimental treatment of cerebral malaria. Int. J. Parasitol. 36:583-593.
11. Granger, D. L., J. B. Hibbs, Jr., J. R. Perfect, and D. T. Durack. 1990. Metabolic fate of L-arginine in relation to microbiostatic capability of murine macrophages. J. Clin. Investig. 85:264-273.
12. Green, B., and S. B. Duffull. 2003. Development of a dosing strategy for enoxaparin in obese patients. Br. J. Clin. Pharmacol. 56:96-103.
13. Hishikawa, K., T. Nakaki, M. Tsuda, H. Esumi, H. Ohshima, H. Suzuki, T. Saruta, and R. Kato. 1992. Effect of systemic L-arginine administration on hemodynamics and nitric oxide release in man. Jpn. Heart J. 33:41-48.
14. Iyengar, R., D. J. Stuehr, and M. A. Marletta. 1987. Macrophage synthesis of nitrite, nitrate, and N-nitrosamines: precursors and role of the respiratory burst. Proc. Natl. Acad. Sci. USA 84:6369-6373.
15. Karyana, M., L. Burdarm, S. Yeung, E. Kenangalem, N. Wariker, R. Maristela, K. Gde Umana, R. Vemuri, M. J. Okoseray, P. M. Penttinen, P. Ebsworth, P. Sugiarto, N. M. Anstey, E. Tjitra, and R. N. Price. 2008. Malaria morbidity in Papua Indonesia, an area with multidrug resistant Plasmodium vivax and Plasmodium falciparum. Malaria J. 7:148.
16. Lopansri, B. K., N. M. Anstey, J. B. Weinberg, G. J. Stoddard, M. R. Hobbs, M. C. Levesque, E. D. Mwaikambo, and D. L. Granger. 2003. Low plasma arginine concentrations in children with cerebral malaria and decreased nitric oxide production. Lancet 361:676-678.
17. Lorente, J. A., L. Landin, R. De Pablo, E. Renes, and D. Liste. 1993. L-arginine pathway in the sepsis syndrome. Crit. Care Med. 21:1287-1295.
18. Mandema, J. W., D. Verotta, and L. B. Sheiner. 1992. Building population pharmacokinetic-pharmacodynamic models. I. Models for covariate effects. J. Pharmacokinet. Biopharm. 20:511-528.
19. Morris, S. M., Jr. 2004. Enzymes of arginine metabolism. J. Nutr. 134:2743S-2747S.
20. Pino, P., I. Vouldoukis, N. Dugas, M. Conti, J. Nitcheu, B. Traore, M. Danis, B. Dugas, and D. Mazier. 2004. Induction of the CD23/nitric oxide pathway in endothelial cells downregulates ICAM-1 expression and decreases cytoadherence of Plasmodium falciparum-infected erythrocytes. Cell. Microbiol. 6:839-848.
21. Ratcliff, A., H. Siswantoro, E. Kenangalem, R. Maristela, R. M. Wuwung, F. Laihad, E. P. Ebsworth, N. M. Anstey, E. Tjitra, and R. N. Price. 2007. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison. Lancet 369:757-765.
22. Roberts, I., and I. M. Smith. 1984. A simple method for the measurement of arginine in serum. Ann. Clin. Biochem. 21:515-518.
23. Serirom, S., W. H. Raharjo, K. Chotivanich, S. Loareesuwan, P. Kubes, and M. Ho. 2003. Anti-adhesive effect of nitric oxide on Plasmodium falciparum cytoadherence under flow. Am. J. Pathol. 162:1651-1660.
24. Stuehr, D., S. Pou, and G. M. Rosen. 2001. Oxygen reduction by nitric-oxide synthases. J. Biol. Chem. 276:14533-14536.
25. Tangphao, O., M. Grossmann, S. Chalon, B. B. Hoffman, and T. F. Blaschke. 1999. Pharmacokinetics of intravenous and oral L-arginine in normal volunteers. Br. J. Clin. Pharmacol. 47:261-266.
26. Tjitra, E., S. Suprianto, B. J. Currie, P. S. Morris, J. R. Saunders, and N. M. Anstey. 2001. Therapy of uncomplicated falciparum malaria: a randomized trial comparing artesunate plus sulfadoxine-pyrimethamine versus sulfadoxine-pyrimethamine alone in Irian Jaya, Indonesia. Am. J. Trop. Med. Hyg. 65:309-317.
27. van Haeften, T. W., and C. H. Konings. 1989. Arginine pharmacokinetics in humans assessed with an enzymatic assay adapted to a centrifugal analyzer. Clin. Chem. 35:1024-1026.
28. van Wandelen, C., and S. A. Cohen. 1997. Using quaternary high-performance liquid chromatography eluent systems for separating 6-aminoquinolyl-N-hydroxysuccinimidylcarbamate-derivatized amino acid mixtures. J. Chromatog. A 763:11-22.
29. Villalpando, S., J. Gopal, A. Balasubramanyam, V. P. Bandi, K. Guntupalli, and F. Jahoor. 2006. In vivo arginine production and intravascular nitric oxide synthesis in hypotensive sepsis. Am. J. Clin. Nutr. 84:197-203.
30. Wang, W., S. Wang, L. Yan, P. Madara, A. Del Pilar Cintron, R. A. Wesley, and R. L. Danner. 2000. Superoxide production and reactive oxygen species signaling by endothelial nitric-oxide synthase. J. Biol. Chem. 275:16899-16903.
31. World Health Organization. 2000. Severe falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 94(Suppl. 1):S1-S90.
32. Wu, G., and S. M. Morris, Jr. 1998. Arginine metabolism: nitric oxide and beyond. Biochem. J. 336:1-17.
33. Yeo, T. W., D. A. Lampah, R. Gitawati, E. Tjitra, E. Kenangalem, D. L. Granger, J. B. Weinberg, B. K. Lopansri, R. N. Price, D. S. Celermajer, S. B. Duffull, and N. M. Anstey. 2008. Safety profile of L-arginine infusion in moderately severe falciparum malaria. PLoS ONE 3:e2347.
34. Yeo, T. W., D. A. Lampah, R. Gitawati, E. Tjitra, E. Kenangalem, Y. R. McNeil, C. J. Darcy, D. L. Granger, J. B. Weinberg, B. K. Lopansri, R. N. Price, S. B. Duffull, D. S. Celermajer, and N. M. Anstey. 2007. Impaired nitric oxide bioavailability and L-arginine reversible endothelial dysfunction in adults with falciparum malaria. J. Exp. Med. 204:2693-2704.
35. Zani, B. G., and H. G. Bohlen. 2005. Transport of extracellular l-arginine via cationic amino acid transporter is required during in vivo endothelial nitric oxide production. Am. J. Physiol. Heart Circ. Physiol. 289:H1381-H1390.